TITLE

Application of anti-mullerian hormone (AMH) in female reproduction

AUTHOR(S)
Mohammadzadeh, J.; Aliyari, M.; Nemati, N.; Shahsavan, M.
PUB. DATE
June 2014
SOURCE
Iranian Journal of Reproductive Medicine;Jun2014 Supplement, Vol. 12, p62
SOURCE TYPE
Academic Journal
DOC. TYPE
Abstract
ABSTRACT
Introduction: Anti-Milllerian hormone (AMH) is a dimeric glycoprotein, a member of the transforming growth factor (TGF) superfamily. In the ovary AMH is produced by the granulosa cells of early developing follicles and seems to be able to inhibit the initiation of primordial follicle growth and FSH induced follicle growth. Materials and Methods: This research designed based on evaluation of 35 articles for about AMH in variety of clinical situations. Results: levels of AMH may represent both the quantity and quality of the ovarian follicle pool. Compared to other ovarian tests, AMH seems to be the best marker reflecting the decline of reproductive age. AMH values have greater sensitivity than Inhibin B, FSH and Estradiol values in predicting ovarian follicular reserve, but combining AMH, Inhibin B and FSH modestly improves the predictive statistics. This predictive value could be improved in poor responders by combining the measure of AFC with these biochemical markers. AMH measurement could be useful in the prediction of the menopausal transition, ovarian reserve; polycystic ovary syndrome (PCOS) and ovarian cancer .Furthermore predicted early menopause with AMH measuring could emphasize the need for timely prevention of bone demineralization and cardiovascular diseases. It could also be used to predict poor ovarian response and prognosis of in vitro fertilization (IVF) cycles. Conclusion: In this article we have shown that AMH can be a novel marker to prediction or diagnosis a spectrum of clinical situations from ovarian reserve to ovarian cancer.
ACCESSION #
96841630

 

Related Articles

  • Anti-Mullerian hormone: reality check. Clark, Christine A.; Laskin, Carl A.; Cadesky, Kenneth // Human Reproduction;Jan2014, Vol. 29 Issue 1, p184 

    No abstract available.

  • New Diagnostic Criteria of Polycystic Ovarian Morphology for Adolescents: Impact on Prevalence and Hormonal Profile. Merino, Paulina M.; Villarroel, Claudio; Jesam, Cristián; López, Patricia; Codner, Ethel // Hormone Research in Paediatrics;Dec2017, Vol. 88 Issue 6, p401 

    Background: The ultrasonographic criteria used to identify polycystic ovarian morphology (PCOM) during adolescence have changed over time. Recently, a Worldwide Pediatric Consensus (PedC) defined PCOM using stricter criteria than the previous recommendations of the Rotterdam Consensus (RC) and...

  • In vitro fertilization treatment in patients with polycystic ovaries. Shulman, Adrian; Dor, Jehoshua // Journal of Assisted Reproduction & Genetics;Jan97, Vol. 14 Issue 1, p7 

    Studies the in vitro fertilization treatment in patients with polycystic ovaries. Includes infertility treatment which is directed toward induction or improvement of ovulation; Gonadotropin preparations as the next treatment of choice; Effect of in vitro fertilization and embryo transfer in...

  • Treatment of polycystic ovary patients undergoing IVF. Barri, P.N.; Coroleu, B. // Journal of Assisted Reproduction & Genetics;Jan97, Vol. 14 Issue 1, p10 

    Discusses the method of treatment for patients with polycystic ovarian syndrome undergoing in vitro fertilization (IVF). Characteristics of patients with PCOS; Advantages of using a pituitary suppression protocol with gonadotropin releasing hormone analogue; Effect of PCOS on the quality of...

  • The treatment of patients with polycystic ovaries undergoing IVF. Franks, Stephen // Journal of Assisted Reproduction & Genetics;Jan97, Vol. 14 Issue 1, p12 

    Studies the treatment of patients with polycystic ovarian syndrome (PCOS) undergoing in vitro fertilization (IVF). Effect of superovulation therapy on estradiol concentrations; Effect of premature increase in the luteinizing hormone (LH) levels during follicular development; Development of...

  • Different Levels Associated with Oocyte Quality, Embryo Development Parameters & ICSI Outcome.  // Fertility Weekly;3/12/2012, p3 

    The article reports on a study which examines the relationship between different basal serum levels of anti-Mullerian hormone (AMH) and oocyte-embryo quality and in vitro fertilization (IVF) outcomes in Turkey. The study analyzes 209 infertile women who underwent IVF treatment with...

  • Antimullerian hormone levels are inversely associated with body mass index (BMI) in women with polycystic ovary syndrome. Kriseman, Maya; Mills, Charity; Kovanci, Ertug; Sangi-Haghpeykar, Haleh; Gibbons, William // Journal of Assisted Reproduction & Genetics;Sep2015, Vol. 32 Issue 9, p1313 

    Purpose: The purpose of this paper is to determine whether antimullerian hormone (AMH) levels were associated with BMI in patients with diagnosed infertility, and more specifically, in patients with polycystic ovarian syndrome (PCOS). Methods: A retrospective cohort study reviewed all females...

  • Oocyte quality in polycystic ovaries revisited: Identification of a particular subgroup of women. Cano, Fidel; Garcia-Velasco, Juan A. // Journal of Assisted Reproduction & Genetics;May97, Vol. 14 Issue 5, p254 

    Assesses the endocrine status of women with polycystic ovaries (PCO) undergoing in vitro fertilization (IVF). Comparison of oocyte quality with endocrine markers of PCO; IVF performance of oocytes derived from PCO women; Association between peripheral insulin resistance and PCO; Subgroup of...

  • Oocyte in-vitro maturation: BCL2 mRNA content in cumulus cells reflects oocyte competency. Filali, M.; Frydman, N.; Belot, M. P.; Hesters, L.; Gaudin, F.; Tachdjian, G.; Emilie, D.; Frydman, R.; Machelon, V. // Reproductive BioMedicine Online (Reproductive Healthcare Limited;Dec2009 Supplement 4, Vol. 19 Issue S4, Special section p1 

    BCL2-associated X protein (BAX) and B-cell leukaemia/lymphoma gene-2 (BCL2), which are, respectively, pro- and anti-apoptotic proteins of the BCL2 gene family, participate in the mitochondria-dependent apoptosis pathway. A correlation between low incidence of apoptosis in cumulus cells and...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics